CORCEPT THERAPEUTICS INC Interest Receivable, Current
CORCEPT THERAPEUTICS INC (CORT) had Interest Receivable, Current of $4.50 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › and Others
us-gaap:InterestReceivableCurrent · last filed 2026-07-29
- 2026-06-30: Interest Receivable, Current $4.50M.
- 2025-12-31: Interest Receivable, Current $4.10M.
- 2025-09-30: Interest Receivable, Current $3.90M.
- 2025-06-30: Interest Receivable, Current $4.10M.
| Period end | Interest Receivable, Current |
|---|---|
| 2026-06-30 | $4.50M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $4.10M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $3.90M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $4.10M 10-Q · filed 2025-07-31 |
| 2024-12-31 | $4.10M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.90M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $2.30M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.70M 10-K · filed 2025-02-26 |
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $600.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.10M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $1.80M 10-K · filed 2024-02-15 |
| 2022-09-30 | $900.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.40M 10-K · filed 2023-02-28 |
| 2021-09-30 | $1.40M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.40M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $1.70M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.30M 10-K · filed 2022-02-15 |
| 2020-09-30 | $1.60M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $1.20M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $1.40M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $1.00M 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |